Showing results (121-130 of 179) with videos related to
Sort By:
Pageof 18
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2008
Analysis of overall survival in patients with nonmetastatic castration-resistant prostate cancer treated with vaccine, nilutamide, and combination therapyRavi A Madan, James L Gulley, Jeffrey Schlom, et al.BJU International|December 13, 2006
Routine interval computed tomography to detect new soft-tissue disease might be unnecessary in patients with androgen-independent prostate cancer and metastasis only to boneShenhong L Wu, Elizabeth Jones, James L Gulley, et al.Journal of Pediatric Urology|May 14, 2025
Early spontaneous resolution of vesicoureteral reflux from voiding cystourethrogram: A comparison of contemporary prediction modelsAdree Khondker, Jin Kyu Kim, Angela M Arlen, et al.Expert Opinion on Biological Therapy|August 30, 2011
A pilot safety trial investigating a vector-based vaccine targeting carcinoembryonic antigen in combination with radiotherapy in patients with gastrointestinal malignancies metastatic to the liverJames L Gulley, Ravi A Madan, Kwong-Yok Tsang, et al.Journal of Pediatric Urology|February 18, 2014
Magnetic resonance urography for diagnosis of pediatric ureteral strictureAngela M Arlen, Andrew J Kirsch, Scott P Cuda, et al.Journal of Pediatric Urology|December 17, 2014
Vesicoureteral reflux index (VURx): a novel tool to predict primary reflux improvement and resolution in children less than 2 years of ageAndrew J Kirsch, Angela M Arlen, Traci Leong, et al.The Journal of Urology|October 12, 2014
Early effect of American Academy of Pediatrics Urinary Tract Infection Guidelines on radiographic imaging and diagnosis of vesicoureteral reflux in the emergency room settingAngela M Arlen, Laura S Merriman, Jared M Kirsch, et al.International Journal of Cancer|April 3, 2007
Identification of cytotoxic T-lymphocyte epitope(s) and its agonist epitope(s) of a novel target for vaccine therapy (PAGE4)Junko Yokokawa, Tapan K Bera, Claudia Palena, et al.Cancer Chemotherapy and Pharmacology|July 25, 2016
A phase 1 dose-escalation study of NEO-102 in patients with refractory colon and pancreatic cancerMuhammad S Beg, Nilofer S Azad, Sandip P Patel, et al.Frontiers in Immunology|January 23, 2018
Preclinical Characterization of a Novel Monoclonal Antibody NEO-201 for the Treatment of Human CarcinomasMassimo Fantini, Justin M David, Olga Saric, et al.Pageof 18